Suzuken Co., Ltd. (TYO:9987)
4,974.00
-18.00 (-0.36%)
Feb 21, 2025, 3:30 PM JST
Suzuken Revenue
Suzuken had revenue of 641.35B JPY in the quarter ending December 31, 2024, with 3.47% growth. This brings the company's revenue in the last twelve months to 2.41T, up 1.67% year-over-year. In the fiscal year ending March 31, 2024, Suzuken had annual revenue of 2.39T with 3.10% growth.
Revenue (ttm)
2,410.84B
Revenue Growth
+1.67%
P/S Ratio
0.16
Revenue / Employee
184.23M
Employees
13,086
Market Cap
363.58B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 2,386.49B | 71.67B | 3.10% |
Mar 31, 2023 | 2,314.83B | 82.05B | 3.67% |
Mar 31, 2022 | 2,232.77B | 104.56B | 4.91% |
Mar 31, 2021 | 2,128.22B | -85.26B | -3.85% |
Mar 31, 2020 | 2,213.48B | 81.12B | 3.80% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |